These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28122858)

  • 1. Target regimen profiles for treatment of tuberculosis: a WHO document.
    Lienhardt C; Nahid P; Rich ML; Bansbach C; Kendall EA; Churchyard G; González-Angulo L; D'Ambrosio L; Migliori GB; Raviglione M
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28122858
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.
    Caminero JA; Piubello A; Scardigli A; Migliori GB
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28679614
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin-resistant tuberculosis: what is the best initial empiric regimen in Mumbai, India?
    Mullerpattan JB; Nikam C; Sharma U; Rodrigues C; Pinto LM
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28729472
    [No Abstract]   [Full Text] [Related]  

  • 4. Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
    Villar M; Sotgiu G; D'Ambrosio L; Raymundo E; Fernandes L; Barbedo J; Diogo N; Lange C; Centis R; Migliori GB
    Eur Respir J; 2011 Sep; 38(3):730-3. PubMed ID: 21885418
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical treatment of tuberculosis - update 2011].
    von Groote-Bidlingmaier F; Diacon AH
    Ther Umsch; 2011 Jul; 68(7):395-401. PubMed ID: 21728158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis elimination, patients' lives and rational use of new drugs: revisited.
    Tiberi S; D'Ambrosio L; De Lorenzo S; Viggiani P; Centis R; Migliori GB
    Eur Respir J; 2016 Feb; 47(2):664-7. PubMed ID: 26541536
    [No Abstract]   [Full Text] [Related]  

  • 7. Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Jaspard M; Elefant-Amoura E; Melonio I; De Montgolfier I; Veziris N; Caumes E
    Emerg Infect Dis; 2017 Oct; 23(10):1731-2. PubMed ID: 28792382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of antituberculosis drugs: a new proposal based on the most recent evidence.
    Caminero JA; Scardigli A
    Eur Respir J; 2015 Oct; 46(4):887-93. PubMed ID: 26424519
    [No Abstract]   [Full Text] [Related]  

  • 10. Experts sound warning on drug-resistant tuberculosis.
    Traynor K
    Am J Health Syst Pharm; 2009 Apr; 66(7):608. PubMed ID: 19299363
    [No Abstract]   [Full Text] [Related]  

  • 11. Compassionate use of bedaquiline in the treatment of pulmonary XDR-TB.
    Danckers M; Lesko MB; Adamson R; Leibert E
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1522-3. PubMed ID: 25517823
    [No Abstract]   [Full Text] [Related]  

  • 12. Extensively drug-resistant tuberculosis: is its definition correct?
    Caminero JA
    Eur Respir J; 2008 Nov; 32(5):1413-5. PubMed ID: 18978145
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial extensively drug-resistant tuberculosis in an HIV-infected child: a case report and review of literature.
    Uppuluri R; Shah I
    J Int Assoc Provid AIDS Care; 2014; 13(2):117-9. PubMed ID: 24401768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of tuberculosis. Current standards].
    Schaberg T
    Internist (Berl); 2015 Dec; 56(12):1379-88. PubMed ID: 26631087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis.
    Payen MC; De Wit S; Martin C; Sergysels R; Muylle I; Van Laethem Y; Clumeck N
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):558-60. PubMed ID: 22325421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
    Maryandyshev A; Pontali E; Tiberi S; Akkerman O; Ganatra S; Sadutshang TD; Alffenaar JW; Amale R; Mullerpattan J; Topgyal S; Udwadia ZF; Centis R; D'Ambrosio L; Sotgiu G; Migliori GB
    Emerg Infect Dis; 2017 Oct; 23(10):1718-21. PubMed ID: 28758888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms by which thioridazine in combination with antibiotics cures extensively drug-resistant infections of pulmonary tuberculosis.
    Amaral L; Molnar J
    In Vivo; 2014; 28(2):267-71. PubMed ID: 24632985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
    Mitrzyk BM
    Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
    Yew WW; Koh WJ
    Korean J Intern Med; 2016 Jan; 31(1):15-29. PubMed ID: 26767853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.